Iran's Fentanyl Weapons: Rising Chemical Threats and Global Implications

Report: Iran Develops Fentanyl-Based Chemical Weapons

According to a recent report from Business Insider, Iran is suspected of developing pharmaceutical-based agents (PBAs) with lethal or incapacitating properties. These PBAs function by affecting the victim's central nervous system, resulting in severe harm or death. The situation may escalate dangerously if these advanced tools are provided to Iran's militant allies, such as Hezbollah and Hamas.

Pharmaceutical-Based Agents: A New Approach in Warfare

An expert from the US claims that Iran has developed synthetic opioid-based chemical weapons, such as fentanyl. These powerful agents have the potential to incapacitate both military personnel and civilians if incorporated into artillery or grenades. PBAs, which are essentially weaponized medicines, function by incapacitating or killing their victims, depending on the exposure levels. Reports also suggest that Iran might have distributed PBAs among proxies like Hezbollah, which runs the risk of utilizing them against Israeli military and civilians.

The U.S. Government Accountability Office describes PBAs as chemicals based on pharmaceutical compounds, some of which have legitimate medical uses. However, misuse of these substances can cause devastating illness or death. Opioids such as fentanyl and sedatives used for veterinary purposes are included in this category.

Lethality of PBAs and Strategies to Counter

Victims exposed to these drugs suffer a significant impact on their central nervous system, potentially leading to a complete loss of consciousness. This gives the deploying party an advantage, allowing them to advance unnoticed and capture the incapacitated victims.

During the Iran-Iraq War in the 1980s, Iran itself was a victim of chemical weapons that led to almost a million casualties. Regardless of their past experiences, there's evidence of Iran using PBAs against rebels during the Syrian Civil War and reports suggesting Iran-backed militias in Iraq might have deployed them against anti-government protesters.

There is international concern that Iran is breaking the 1997 Chemical Weapons Convention by developing these pharmaceutical-based weapons. The Convention prohibits the creation and use of toxic chemicals, defined as those that can inflict death, temporary incapacitation, or permanent harm to humans or animals. All signatories to the treaty, including Iran, are required to destroy any existing stockpiles.

Detection and Difficulties in Regulating PBAs

Despite the growing evidence pointing to Iran's continued development of PBAs, regulating them poses a significant challenge due to overlaps with legal law enforcement and medical applications. The concern around Iran and PBAs grows if Tehran has passed these weaponized medicines to proxies like Hezbollah, as these actions can provide Iran plausible deniability. PBAs could be used strategically to incapacitate border guards or soldiers.

While the recent Israeli military offensives have significantly weakened Hezbollah and its missile arsenal, the group still holds considerable stocks of smaller weapons that can be paired with PBAs. With the chance of encounters between US forces and Iran and its allies, the potential risk of pharmaceutical-based agents couldn't be higher.